Kurs
-0,61%
Likviditet
0,27 MEUR
Kalender
| Tid* | ||
| 2025-10-23 | 08:00 | Kvartalsrapport 2025-Q3 |
| 2025-07-17 | 08:00 | Kvartalsrapport 2025-Q2 |
| 2025-04-25 | 08:00 | Kvartalsrapport 2025-Q1 |
| 2025-04-08 | N/A | Årsstämma |
| 2025-02-14 | 08:00 | Bokslutskommuniké 2024 |
| 2024-10-25 | - | Kvartalsrapport 2024-Q3 |
| 2024-10-08 | - | X-dag halvårsutdelning TTALO 0.15 |
| 2024-07-17 | - | Kvartalsrapport 2024-Q2 |
| 2024-04-26 | - | Kvartalsrapport 2024-Q1 |
| 2024-03-27 | - | X-dag halvårsutdelning TTALO 0.15 |
| 2024-03-26 | - | Årsstämma |
| 2024-02-14 | - | Bokslutskommuniké 2023 |
| 2023-10-27 | - | Kvartalsrapport 2023-Q3 |
| 2023-09-29 | - | X-dag halvårsutdelning TTALO 0.14 |
| 2023-07-18 | - | Kvartalsrapport 2023-Q2 |
| 2023-04-28 | - | Kvartalsrapport 2023-Q1 |
| 2023-03-24 | - | X-dag halvårsutdelning TTALO 0.14 |
| 2023-03-23 | - | Årsstämma |
| 2023-02-10 | - | Bokslutskommuniké 2022 |
| 2022-10-27 | - | Kvartalsrapport 2022-Q3 |
| 2022-10-07 | - | X-dag halvårsutdelning TTALO 0.14 |
| 2022-07-19 | - | Kvartalsrapport 2022-Q2 |
| 2022-04-28 | - | Kvartalsrapport 2022-Q1 |
| 2022-04-08 | - | X-dag halvårsutdelning TTALO 0.14 |
| 2022-04-07 | - | Årsstämma |
| 2022-02-10 | - | Bokslutskommuniké 2021 |
| 2021-10-29 | - | X-dag halvårsutdelning TTALO 0.13 |
| 2021-10-28 | - | Kvartalsrapport 2021-Q3 |
| 2021-08-12 | - | Kvartalsrapport 2021-Q2 |
| 2021-04-29 | - | Kvartalsrapport 2021-Q1 |
| 2021-03-26 | - | X-dag halvårsutdelning TTALO 0.13 |
| 2021-03-25 | - | Årsstämma |
| 2021-02-11 | - | Bokslutskommuniké 2020 |
| 2020-10-29 | - | Kvartalsrapport 2020-Q3 |
| 2020-08-06 | - | Kvartalsrapport 2020-Q2 |
| 2020-07-01 | - | X-dag ordinarie utdelning TTALO 0.13 EUR |
| 2020-05-28 | - | Årsstämma |
| 2020-05-06 | - | Kvartalsrapport 2020-Q1 |
| 2020-04-03 | - | X-dag halvårsutdelning TTALO 0.13 |
| 2020-02-13 | - | Bokslutskommuniké 2019 |
| 2019-10-31 | - | Kvartalsrapport 2019-Q3 |
| 2019-08-08 | - | Kvartalsrapport 2019-Q2 |
| 2019-05-09 | - | Kvartalsrapport 2019-Q1 |
| 2019-04-05 | - | X-dag ordinarie utdelning TTALO 0.20 EUR |
| 2019-04-04 | - | Årsstämma |
| 2019-02-14 | - | Bokslutskommuniké 2018 |
| 2018-11-14 | - | Kvartalsrapport 2018-Q3 |
| 2018-08-17 | - | Kvartalsrapport 2018-Q2 |
| 2018-05-16 | - | Kvartalsrapport 2018-Q1 |
| 2018-04-13 | - | X-dag ordinarie utdelning TTALO 0.06 EUR |
| 2018-04-12 | - | Årsstämma |
| 2018-02-28 | - | Bokslutskommuniké 2017 |
Beskrivning
| Land | Finland |
|---|---|
| Lista | Mid Cap Helsinki |
| Sektor | Hälsovård |
| Industri | Vård & Omsorg |
Terveystalo Plc, stock exchange release 6 August 2024 at 9:00 a.m. EEST
Petri Bono, who has served as Terveystalo's Chief Medical Officer and member of the Executive Team since 2019, has announced that he will leave the company on 14 August 2024 to take up a new position outside the company.
- Under Petri's leadership, a strong team has been built in the medical management and our quality is among the best in the industry. I warmly thank Petri for his excellent work, for example, in managing the challenging coronavirus years and taking our medical management structure to a new model. In line with our strategy, the focus of our medical development will increasingly shift to customer-oriented development of integrated treatment paths and measuring their effectiveness. Medical line management plays a key role in this work, and we have a solid team to take this work forward, says Ville Iho, President and CEO of Terveystalo.
- I am deeply proud of the pioneering quality work that Terveystalo has been developing for over five years. We have taken medical quality and the management of entire care pathways to a new level and modernised healthcare by incorporating innovative health technology to health check-ups. These changes will finally shift the focus of healthcare towards prevention, which is a prerequisite for the future sustainability of the healthcare system. Now is the time to move forward, and I am confident that Terveystalo will continue to be at the forefront of innovation and medical quality also in the future. A heartfelt thank you to the entire team for this journey and shared achievements," said Petri Bono.
The responsibilities of the Chief Medical Officer of Terveystalo Group will be shared between the company's medical management for the time being. The operational medical management of the business areas has already been strengthened in the past as part of the reorganisation of Terveystalo's operating model.
Terveystalo Plc
More information:
Kati Kaksonen,
Vice President, Investor Relations and Sustainability
Tel. 010 345 2034
kati.kaksonen@terveystalo.com
Distribution:
Nasdaq Helsinki Oy
Principal media
www.terveystalo.com